norethindrone has been researched along with levonorgestrel in 235 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 92 (39.15) | 18.7374 |
| 1990's | 79 (33.62) | 18.2507 |
| 2000's | 41 (17.45) | 29.6817 |
| 2010's | 16 (6.81) | 24.3611 |
| 2020's | 7 (2.98) | 2.80 |
| Authors | Studies |
|---|---|
| Kollman, PA; Lee, DL; Marsh, FJ; Wolff, ME | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Baber, R; Flemming, CL; Johnston, H; Jones, M; Monaghan, JC; Pinkerton, G; Stokes, GS | 1 |
| Balabaud, C; Bioulac-Sage, P; Deugnier, Y; Jouhanole, H; Le Bail, B; Pellegrin, JL; Salame, G; Saric, J | 1 |
| Cullins, VE | 1 |
| Hall, PE; Holck, S; Loke, DF; Ng, CS; Ratnam, SS | 1 |
| Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
| Emans, SJ; Grace, E; Havens, KK; Merola, JL; Woods, ER | 1 |
| Christiansen, C; Haarbo, J; Svendsen, OL | 1 |
| Carlier, PG; Fradin, EA; Gilles, RG; Rorive, GL; Vaesen, F | 1 |
| Ashwell, E; Ball, MJ; Gillmer, MD | 1 |
| Barja, P; Bocaz, JA; Bonnar, J; Carrol, A; Coutinho, E; Daly, L; Goncalves, M; Leck, I; Thomson, JM; Tsakok, M | 1 |
| Cassidenti, DL; Lobo, RA; Paulson, RJ; Serafini, P; Stanczyk, FZ | 1 |
| Shaaban, MM | 1 |
| Christiansen, C; Haarbo, J; Leth-Espensen, P; Stender, S | 1 |
| Christiansen, C; Haarbo, J; Hansen, BF | 1 |
| Darney, PD | 2 |
| Das, K; Engineer, AD; Misra, JS; Tandon, P | 1 |
| Garza-Flores, J; Hall, PE; Perez-Palacios, G | 1 |
| Hager, SR; Kalkhoff, RK | 1 |
| Aedo, AR; Dada, O; Diczfalusy, E; Johannisson, E; Landgren, BM | 1 |
| Angel de Toro, LA; Lavarello, AC; Roncales Mateo, JM; Sagasta, CL; Salas Diaz, R; Wiemeyer, JC | 1 |
| Ellingson, AB; Spellacy, WN; Tsibris, JC | 1 |
| Broome, M; Fotherby, K | 1 |
| Andersch, B; Milsom, I; Sundell, G | 1 |
| Hümpel, M; Li, QG | 1 |
| Fotherby, K | 2 |
| Roy, S; Stanczyk, FZ | 1 |
| Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Apelo, R; Osteria, T; Ramos, R; Vilar, E | 1 |
| Goldzieher, JW | 1 |
| Chen, JK; Fotherby, K; He, ML; Song, S | 1 |
| Karunanithy, R; Leung, SL; Yeo, SH | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Florio, V; Morini, A; Mossa, B; Roscetti, C | 1 |
| Aleksandrovskaia, TN; Dubnitskaia, LV; Manuilova, IA; Shallaeva, VV | 1 |
| Keller, PJ | 1 |
| Odlind, V | 1 |
| Fraser, IS | 1 |
| Hoppe, G | 1 |
| Bonnar, J | 1 |
| Belsey, EM | 1 |
| Varma, TR | 2 |
| Rådberg, G; Svanvik, J | 1 |
| Annus, J; Apró, G; Bartfai, G; Belsey, E; Bulpitt, C; Kovacs, L; Pinol, A | 1 |
| Joshi, JV; Joshi, UM; Sankolli, GM; Shah, RS | 1 |
| Hale, R | 1 |
| Back, DJ; el-Raghy, I; Fathalla, M; Makeram, M; Orme, ML; Osman, F; Salem, H | 1 |
| Godsland, I; Wynn, V | 1 |
| Bonnar, J; Hourihan, HM; Sheppard, BL | 1 |
| Betrabet, SS; Patel, D; Saxena, BN; Shikary, ZK; Toddywalla, SP; Toddywalla, VS | 1 |
| Gillmer, MD | 1 |
| Hale, RW | 1 |
| Nattrass, M; Nutter, SA; Singh, BM | 1 |
| Ahlesteen, I; Astedt, B; Kjaeldgaard, A; Larsson, B | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Nair, KM; Prasad, KV; Rao, BS; Sivakumar, B | 2 |
| von Schoultz, B | 1 |
| Donde, UM; Joshi, JV; Joshi, UM; Sankoli, GM; Saxena, BN; Virkar, KD | 1 |
| Tiltman, AJ | 1 |
| Heller, J; Himmelstein, KJ | 1 |
| Becket, G; Karunanithy, R; Leung, SL; Yeo, SH | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Back, DJ; Breckenridge, A; Orme, M; Shaw, MA | 1 |
| Freund, H; Freund, R; Kurischko, A; Meyer, M; Oettel, M; Stölzner, W | 1 |
| de Visser, J; van der Vies, J | 1 |
| Klove, KL; Lobo, RA; Roy, S | 1 |
| Düsterberg, B | 1 |
| Casagrande, J; Krauss, RM; Mishell, DR; Pike, MC; Roy, S | 1 |
| Briggs, M | 2 |
| Chan, L; Hadjigeogiou, P; Matlin, SA; Mehani, S; Prazeres, MA; Roshdi, S | 1 |
| Fotherby, K; Naderi, S | 1 |
| Bialy, G; Blye, RP; Enever, RP; Lindberg, MC; Naqvi, RH | 1 |
| Puolakka, J; Viinikka, L; Ylikorkala, O | 1 |
| Delezé, M; Gutiérrez, G; Mintz, G; Rodríguez, E | 1 |
| Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES | 1 |
| el-Kabsh, MY; Elwan, SI; Farghaly, SA; Shaaban, MM; Thabet, N | 1 |
| Düsterberg, B; Hümpel, M; Speck, U | 1 |
| Gustafson, A; Samsioe, G; Silfverstolpe, G; Svanborg, A | 2 |
| Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST | 1 |
| Fotherby, K; Jenkins, N | 2 |
| Elstein, M; Nuttal, ID | 1 |
| Alvarado Durán, A; Aznar, R; Gallegos, A; González Diddí, M; Pedrón, N | 1 |
| Kay, CR | 1 |
| Niththyananthan, R; Wynn, V | 1 |
| Meade, TW | 1 |
| Adatia, A; Andolsek, L; Ayeni, S; Belsey, MA; Hall, PE; Jain, U; Li Hoi Foo, C; Parker, RA; Patankar, S; Pinol, A; Pretnar-Darovec, A; Sharma, S; Sheth, A | 1 |
| Wingrave, SJ | 1 |
| Back, DJ; Breckenridge, AM; MacIver, M; Orme, M; Rowe, PH; Staiger, C; Thomas, E; Tjia, J | 1 |
| Hodsman, GP; Mackay, A; Robertson, JI; Semple, PF | 1 |
| Weir, RJ | 1 |
| Bolt, HM; Jung, R; Oesch, F; Peter, H | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Hales, HA; Hatasaka, HH; Jones, KP; Mainwaring, R; Peterson, CM; Poulson, AM; Stevenson, K | 1 |
| Datey, S; Gaur, LN; Saxena, BN | 1 |
| Kauppila, AJ; Laatikainen, TJ; Paakkari, IA; Raudaskoski, TH; Tomás, EI | 1 |
| Berenson, AB; Wiemann, CM | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Caird, LE; Glasier, AF; Gow, S; Hannan, WJ; Reid-Thomas, V | 1 |
| Doğan, P; Köse, K; Ozesmi, C | 3 |
| Nordby, J; Paulsen, JE; Wiik, P | 1 |
| Chambers, HM; Eckert, K; MacLennan, A; MacLennan, AH; Wenzel, S | 1 |
| Anstee, P; Kovacs, GT | 1 |
| Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
| Broome, M; Clayton, J; Fotherby, K | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Gaspard, UJ; Hendrick, JC; Nervo, P; van den Brûle, FA | 1 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Camacho-Arroyo, I; Cerbón, MA; García, GA; Pasapera, AM; Pérez-Palacios, G; Pichon, C; Savouret, JF | 1 |
| Dören, M; Schneider, HP | 1 |
| Kovacs, G | 1 |
| Affandi, B; Hadisaputra, W; Rogers, PA; Siregar, B; Wonodirekso, S | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Diffey, B; O'Dea, K; Piers, LS; Soares, MJ | 1 |
| Cameron, IT; Campbell, S; Church, HJ; Irvine, GA; Kohnen, G; MacLachlan, F; Titterington, M | 1 |
| Duckitt, K; Shaw, RW | 1 |
| Cameron, IT; Campbell-Brown, MB; Heikkilä, A; Irvine, GA; Lumsden, MA; Walker, JJ | 1 |
| Gard, PR; Malhi, JS; Ostad, SN | 1 |
| Fernández-Guasti, A; García, GA; Lemus, AE; Picazo, O | 1 |
| Berg, G; Brenner, H; Kohlmeier, L | 1 |
| Dorea, JG; Myazaki, E | 1 |
| Knip, M; Laatikainen, T; Raudaskoski, T | 1 |
| Graff-Iversen, S; Lund-Larsen, PG; Nodarse, LO; Stensvold, I; Tverdal, A; Urdal, P | 1 |
| Hampton, AL; Nie, G; Salamonsen, LA | 1 |
| Chavez, A; DelConte, A | 1 |
| Choy, CC; Paul, AC | 1 |
| Gast, MJ; Martin, D; Reisman, H | 1 |
| Bouchoux, F; Degryse, M; Gaillard, M; Lecaque, D; Petit, F; Philibert, D | 1 |
| Agrawal, R; Conway, GS; Ginsburg, J; Jacobs, HS; Payne, NN; Prelevic, G | 1 |
| Edgren, RA; Stanczyk, FZ | 1 |
| Ballagh, SA; Bradshaw, KD; Nichols, M; Stanczyk, FZ; Thorneycroft, IH; Weber, ME | 1 |
| Baker, HW; Hendricks, J; Kovacs, GT; Summerbell, D | 1 |
| Dórea, JG | 1 |
| Avari, KM; Bhiwgade, DA; Borkar, MR | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Hite, R; Schmidt, W | 1 |
| Meczekalski, B; Słopień, R; Warenik-Szymankiewicz, A | 1 |
| Grimes, D; Helmerhorst, F; Schulz, K; Van Vliet, H | 1 |
| Harwood, B; Mishell, DR | 1 |
| García-Becerra, R; Gutiérrez-Sagal, R; Pasapera, AM; Savouret, JF; Ulloa-Aguirre, A | 1 |
| Andersen, LF; Gram, J; Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 1 |
| Grimes, DA; Helmerhorst, FM; Schulz, KF; van Vliet, HA | 3 |
| Graff-Iversen, S; Tonstad, S | 1 |
| Honjo, H; Hosoda, T; Kitawaki, J; Tanaka, K; Tatsumi, H | 1 |
| Bertrand, J; Jallatte, CS; Renaud, M; Soutoul, JH | 1 |
| Prema, K | 1 |
| Fritzinger, BK; Heller, J; Helwing, RF; Penhale, DW; Rose, JE | 1 |
| Potts, DM; Siemens, AJ | 1 |
| Arshat, H | 1 |
| Chen, JK | 1 |
| Rozenbaum, H | 2 |
| Belaisch, J | 1 |
| Wynn, V | 1 |
| Hahn, DW; Mcguire, JL; Philipps, A | 1 |
| Olsson, SE | 1 |
| Gonzalez-ansorena, R; Rubio-lotvin, B; Ruiz-moreno, JA | 1 |
| Adams, J; Guillebaud, J; Jacobs, HS; Tayob, Y | 1 |
| Maclennan, AH | 1 |
| Chen, JK; Gui, YL; He, ML; Li, LM; Yang, PJ | 1 |
| Smith, M | 1 |
| Gao, SM; Shen, WX; Sun, ZD; Wang, HZ; Zheng, SH | 1 |
| Basta, A; Gregoraszczuk, EL; Kolodziejczyk, J; Krzysiek, J; Kurek, S; Milewicz, T; Stachura, J; Sztefko, K | 1 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| Furlong, LA | 1 |
| Lynge, E; Ottesen, B; Pederson, AT; Stahlberg, C | 1 |
| Boon, J; Heintz, AP; Oldenhave, A; Scholten, PC | 1 |
| Stanczyk, FZ | 1 |
| Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ | 1 |
| Bigrigg, A; Gallagher, J; Hesketh, C; Loftus-Granberg, B; Shochet, T; Tyrer, A; Webb, A | 1 |
| Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Borja-Cacho, E; Cooney, AJ; García-Becerra, R; Larrea, F; Lemus, AE; Pérez-Palacios, G | 1 |
| Graff-Iversen, S; Hammar, N; Thelle, DS; Tonstad, S | 1 |
| Fushiki, S; Hirasugi, Y; Honjo, H; Hosoda, T; Iwasa, K; Kawata, M; Kikuchi, N; Kitawaki, J; Mihara, M; Oida, N; Tatsumi, H; Yamamoto, H | 1 |
| Cooke, I; Lethaby, AE; Rees, M | 1 |
| Honkanen, R; Kröger, H; Pentti, K; Saarikoski, S; Sandini, L; Tuppurainen, MT | 1 |
| Shittu, O; Sule, S | 1 |
| Edelman, AB; Jensen, JT; Koontz, SL; Nichols, MD | 1 |
| Grimes, DA; Helmerhorst, FM; Lopez, LM; Schulz, KF; van Vliet, HA | 2 |
| Bowen, CL; Licea-Perez, H; Wang, S; Yang, E | 1 |
| Arzate, H; Chimal-Monroy, J; Enríquez, J; García, GA; Herrero, B; Larrea, F; Lemus, AE; Pérez-Palacios, G | 1 |
| Brixner, DI; Chang, J; Doyle, JJ; Hagan, M; Hendlish, SK; Horowicz-Mehler, NC; Stern, LS | 1 |
| González, EA; Molina, RC; Molina, TG; Montero, AV; Oyarzún, PG; Sandoval, JZ | 1 |
| Buono, MJ; Martin, JG | 1 |
| Endrikat, J; Fortier, M; Kunz, M; Lukkari-Lax, E; Schmidt, W; Shapiro, H | 1 |
| Aboulfadl, K; Barbeau, B; Broséus, R; Daneshvar, A; Prévost, M; Sauvé, S; Vincent, S | 1 |
| Spark, MJ | 1 |
| Freeman, S; Shulman, LP | 1 |
| Weisberg, E | 1 |
| Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Hel, Z; Huijbregts, RP; Michel, KG | 1 |
| Hussain, M; Lethaby, A; Rees, MC; Rishworth, JR | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Critchley, HO; Maybin, JA | 1 |
| Evliyaoglu, O; Haberal, A; Kayikcioglu, F; Kiseli, M | 1 |
| Acosta, JI; Andrews, MG; Bimonte-Nelson, HA; Braden, BB; Lavery, C; Mennenga, SE | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| AlSharari, SD; Ashraf, MN; Habib-Ur-Rehman, A; Murtaza, G; Shehzad, Z | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Barra, F; Ferrero, S; Leone Roberti Maggiore, U; Scala, C; Venturini, PL | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Akgül, S; Ari, DA; Kanbur, N | 1 |
| Bofill Rodriguez, M; Jordan, V; Lethaby, A | 1 |
| Patel, MV; Rodriguez-Garcia, M; Shen, Z; Wira, CR | 1 |
| Africander, DJ; Avenant, C; Hapgood, JP; Komane, M; Louw-du Toit, R | 1 |
| Brown, JD; Cicali, B; Cristofoletti, R; Da Silva, L; Hoechel, J; Kim, S; Lingineni, K; Pressly, M; Sarayani, A; Schmidt, S; Vozmediano, V; Wendl, T; Winterstein, AG | 1 |
| Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J | 1 |
| Blue, S; Boniface, ER; Erikson, DW; Jensen, JT; McCrimmon, S; Waites, BT | 1 |
26 review(s) available for norethindrone and levonorgestrel
| Article | Year |
|---|---|
Injectable and implantable contraceptives.
Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone | 1992 |
Subdermal progestin implant contraception.
Topics: Biodegradation, Environmental; Contraceptives, Oral, Combined; Drug Implants; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic | 1991 |
Long-acting hormonal contraceptives for women.
Topics: Aniline Compounds; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovulation | 1991 |
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Pharmacology of contraceptive steroids: a brief review.
Topics: Biological Availability; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Humans; Levonorgestrel; Norethindrone; Norgestrel | 1989 |
[Hormonal contraception using depot preparations].
Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk | 1986 |
New delivery systems for hormonal contraception.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina | 1986 |
Hormonal implants: contraception for a new century.
Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone | 1994 |
Progestogen-only pills and bleeding disturbances.
Topics: Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Uterine Hemorrhage | 1996 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Pregnancy; Randomized Controlled Trials as Topic | 2001 |
Contraceptive vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norprogesterones; Patient Acceptance of Health Care; Progesterone; Progestins; Vinyl Compounds | 2001 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Ectopic pregnancy risk when contraception fails. A review.
Topics: Clinical Trials as Topic; Contraceptive Agents; Contraceptives, Oral, Synthetic; Drug Approval; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Pregnancy, Ectopic; Product Surveillance, Postmarketing; Progesterone; Treatment Failure; United States; United States Food and Drug Administration | 2002 |
Hormone replacement therapy and risk of breast cancer: the role of progestins.
Topics: Breast Neoplasms; Drug Administration Schedule; Epidemiologic Studies; Estrogen Replacement Therapy; Europe; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Meta-Analysis as Topic; Middle Aged; Norethindrone; Norethindrone Acetate; Progestins; Risk Factors; United States | 2003 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Randomized Controlled Trials as Topic | 2003 |
All progestins are not created equal.
Topics: Animals; Female; Humans; Levonorgestrel; Liver; Models, Chemical; Norethindrone; Pregnanes; Progestins; Rats; Structure-Activity Relationship; Time Factors | 2003 |
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Progesterone | 2005 |
Biphasic versus triphasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Randomized Controlled Trials as Topic | 2006 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2006 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
Triphasic versus monophasic oral contraceptives for contraception.
Topics: Contraception; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norethindrone; Patient Compliance; Randomized Controlled Trials as Topic | 2011 |
Steroid hormones for contraception in men.
Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone | 2012 |
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Randomized Controlled Trials as Topic | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
Medical management of heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Women's Health | 2016 |
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome | 2020 |
51 trial(s) available for norethindrone and levonorgestrel
| Article | Year |
|---|---|
Lipid and biochemical changes after low-dose oral contraception.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Pressure; Blood Proteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Hematocrit; Hemoglobins; Humans; Intrauterine Devices; Levonorgestrel; Norethindrone; Parity; Time Factors; Triglycerides | 1992 |
Progestagen-only oral contraceptives: comparison of the metabolic effects of levonorgestrel and norethisterone.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Blood Pressure; Body Weight; Factor X; Female; Glucose; Glucose Tolerance Test; Hemoglobins; Humans; Levonorgestrel; Lipid Metabolism; Lipoproteins; Norethindrone; Patient Acceptance of Health Care; Risk Factors | 1991 |
A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity. Task Force on Oral Contraceptives--WHO Special Programme of Research, Development and Research Training in Human R
Topics: Adult; Blood Coagulation; Brazil; Chile; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Ethnicity; Female; Fibrinolysis; Hemostasis; Humans; Ireland; Levonorgestrel; Norethindrone; Norethindrone Acetate; Singapore | 1991 |
Contraception with progestogens and progesterone during lactation.
Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology | 1991 |
Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Cholesterol; Coronary Disease; Diet; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Rabbits | 1991 |
Pituitary, ovarian and endometrial effects of 300 micrograms norethisterone and 30 micrograms levonorgestrel administered on cycle days 7 to 10.
Topics: Adult; Contraceptives, Oral, Combined; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Ovary; Pituitary Gland; Progesterone | 1990 |
Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg.
Topics: Adult; Algestone; Algestone Acetophenide; Analysis of Variance; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Copper; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Injections; Levonorgestrel; Multicenter Studies as Topic; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin; Testosterone; Transcortin; Triglycerides; White People | 1990 |
Two-year carbohydrate metabolism studies in women using a norethindrone or levonorgestrel triphasic oral contraceptive.
Topics: Adult; Analysis of Variance; Blood Glucose; Contraceptives, Oral, Combined; Female; Humans; Insulin; Levonorgestrel; Norethindrone; Norgestrel; Prospective Studies | 1990 |
A comparative analysis of three different dose combinations of oral contraceptives.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Headache; Humans; Levonorgestrel; Menstruation Disturbances; Nausea; Norethindrone; Norgestrel; Patient Compliance; Philippines; Pregnancy | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
[Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
Topics: Adolescent; Ambulatory Care; Drug Combinations; Drug Evaluation; Emergencies; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Metrorrhagia; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes | 1989 |
A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects. Report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task force o
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Blood Proteins; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation; Serum Albumin; Triglycerides | 1985 |
Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Norethindrone; Norethindrone Acetate; Norgestrel; Ovulation Detection; Research Design | 1988 |
The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Structure-Activity Relationship; Time Factors | 1986 |
Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Random Allocation | 1986 |
ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Norgestrel; Pregnancy | 1987 |
The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Random Allocation | 1984 |
Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
Topics: Adult; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Lipoproteins; Lipoproteins, HDL; Norethindrone; Norgestrel; Triglycerides | 1983 |
Plasma lipids in women using progestogen-only oral contraceptives.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Female; Humans; Lactation; Levonorgestrel; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Norethindrone; Norgestrel; Pregnancy; Triglycerides | 1983 |
Contraception with progestagens in systemic lupus erythematosus.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Lupus Erythematosus, Systemic; Norethindrone; Norgestrel; Stereoisomerism | 1984 |
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism | 1984 |
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides | 1980 |
Steroid releasing vaginal rings.
Topics: Clinical Trials as Topic; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Medroxyprogesterone; Norethindrone; Norgestrel; Ovulation; Patient Acceptance of Health Care; Progesterone; Progestins | 1980 |
A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles.
Topics: Adult; Blood Proteins; Contraceptives, Oral; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Norgestrel; Random Allocation; Stereoisomerism | 1981 |
A randomized, double-blind study of six combined oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Pregnancy; Random Allocation | 1982 |
A randomized, double-blind study of two combined and two progestogen-only oral contraceptives.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Levonorgestrel; Menstruation; Mestranol; Norethindrone; Norgestrel; Pregnancy; Random Allocation | 1982 |
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Cholesterol; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Triglycerides | 1995 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand | 1994 |
Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids.
Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Reference Values; Single-Blind Method | 1993 |
Continuous low-dose oestrogen and progestogen hormone replacement therapy: a randomised trial.
Topics: Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Estrogens; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Menstruation; Middle Aged; Norethindrone; Progestins; Prospective Studies | 1993 |
A prospective randomized study comparing the clinical effects of a norethisterone and a levonorgestrel containing low dose oestrogen oral contraceptive pills.
Topics: Adolescent; Adult; Breast; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Prospective Studies; Uterine Hemorrhage; Weight Gain | 1993 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Topics: Adult; Female; Ferritins; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Menstruation; Middle Aged; Norethindrone; Patient Satisfaction; Progesterone Congeners; Treatment Outcome; Uterine Hemorrhage | 1998 |
Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Drug Monitoring; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies | 1998 |
A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study.
Topics: Adolescent; Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norethindrone; Uterine Hemorrhage | 1999 |
A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
Topics: Adult; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone | 1999 |
Effect of low-dose oral contraceptives on androgenic markers and acne.
Topics: Acne Vulgaris; Adolescent; Adrenal Glands; Adult; Androgens; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovary; Sex Hormone-Binding Globulin; Testosterone; Weight Gain | 1999 |
Oral contraceptives do not affect magnesium in breast milk.
Topics: Adult; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Ethinyl Estradiol; Family Characteristics; Female; Humans; Levonorgestrel; Magnesium; Maternal Age; Milk, Human; Norethindrone; Social Class; Time Factors | 2000 |
Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Treatment Outcome | 2001 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT.
Topics: Administration, Oral; Climacteric; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norethindrone; Patient Compliance | 2003 |
Effect of hormonal emergency contraception on bleeding patterns.
Topics: Contraceptives, Postcoital, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Interviews as Topic; Levonorgestrel; Menstruation; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted; Safe Sex; Time Factors; Treatment Outcome | 2004 |
Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Topics: Adult; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Patient Satisfaction; Uterine Hemorrhage | 2006 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
Topics: Adult; Canada; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Hemoglobins; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Norethindrone Acetate; Prospective Studies; Severity of Illness Index | 2009 |
Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study.
Topics: Adult; Anemia; Female; Hemostatics; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Reproductive Control Agents; Tranexamic Acid | 2016 |
Clinical efficacy of levonorgestrel and norethisterone for the treatment of chronic abnormal uterine bleeding.
Topics: Administration, Oral; Adult; Chronic Disease; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Treatment Outcome | 2017 |
158 other study(ies) available for norethindrone and levonorgestrel
| Article | Year |
|---|---|
Quantitative relationships between steroid structure and binding to putative progesterone receptors.
Topics: Androstenes; Animals; Guinea Pigs; Humans; Hydroxyprogesterones; Protein Binding; Rabbits; Receptors, Progesterone; Sheep; Steroids; Structure-Activity Relationship | 1977 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Effects of oral contraceptives containing oestrogen combined with norethisterone or levonorgestrel on erythrocyte cation transport in normal women.
Topics: Adolescent; Adult; Aldosterone; Biological Transport, Active; Carrier Proteins; Contraceptives, Oral; Erythrocytes; Estrogens; Female; Humans; Levonorgestrel; Lipids; Norethindrone; Potassium; Renin; Sodium; Sodium-Potassium-Chloride Symporters; Triglycerides | 1992 |
Liver adenomatosis with granulomas in two patients on long-term oral contraceptives.
Topics: Adenoma; Adult; Contraceptives, Oral; Ethinyl Estradiol; Female; Granuloma; Humans; Levonorgestrel; Liver Neoplasms; Middle Aged; Multiple Endocrine Neoplasia; Norethindrone; Time Factors | 1992 |
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive in adolescent patients.
Topics: Adolescent; Black or African American; Contraceptives, Oral; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Patient Compliance; Regression Analysis; Suburban Population; Urban Population; White People | 1992 |
Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Analysis of Variance; Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Estradiol; Female; Levonorgestrel; Lipoproteins; Norethindrone; Norethindrone Acetate; Ovariectomy; Progestins; Rabbits; Random Allocation; Triglycerides | 1992 |
Effect of oral contraception on water-suppressed proton NMR spectra of plasma.
Topics: Adult; Belgium; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Hydrogen; Levonorgestrel; Lipids; Magnetic Resonance Spectroscopy; Middle Aged; Military Personnel; Norethindrone; Norgestrel; Progestins; Protons; Regression Analysis; Water | 1991 |
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Skin; Steroids | 1991 |
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Topics: Animals; Aorta; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Endometrium; Energy Intake; Estradiol; Estradiol Dehydrogenases; Female; Isocitrate Dehydrogenase; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Ovariectomy; Rabbits | 1991 |
Cervical carcinogenesis and contraception.
Topics: Adult; Age Factors; Female; Follow-Up Studies; Humans; Incidence; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Norethindrone; Parity; Progesterone Congeners; Uterine Cervical Dysplasia; Vaginal Smears | 1991 |
Levonorgestrel and norethindrone alter insulin action on skeletal muscle of the female rat.
Topics: Animals; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Female; Glucose; Hindlimb; Insulin; Insulin Antagonists; Insulin Resistance; Levonorgestrel; Muscles; Norethindrone; Norgestrel; Phenylalanine; Progesterone Congeners; Rats; Rats, Inbred Strains | 1990 |
Clinical experience with the progestogen-only pill.
Topics: Adult; Contraception; Contraceptives, Oral, Combined; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Dropouts; Progestins | 1990 |
The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
Topics: Adult; Contraceptives, Oral, Combined; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Lynestrenol; Mestranol; Norethindrone; Norgestrel | 1990 |
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats | 1990 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
Topics: Adult; Ceruloplasmin; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Sex Hormone-Binding Globulin | 1989 |
Correlation of contraceptive activity of norethisterone and levonorgestrel esters with VR(w) values and hydrolysis rates.
Topics: Acetic Anhydrides; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Esterification; Esters; Fluoroacetates; Hydrolysis; Levonorgestrel; Norethindrone; Norgestrel; Regression Analysis; Solubility; Sulfur Oxides; Thermodynamics | 1989 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
[Lipid metabolism in hormonal contraception].
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Levonorgestrel; Lipid Metabolism; Norethindrone; Norgestrel; Time Factors | 1985 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Influence of pregnancy, oophorectomy and contraceptive steroids on gall bladder concentrating function and hepatic bile flow in the cat.
Topics: Absorption; Animals; Bile; Body Water; Cats; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Gallbladder; Levonorgestrel; Norethindrone; Norgestrel; Ovariectomy; Pregnancy; Pregnancy, Animal; Prolactin; Stereoisomerism | 1986 |
Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
Topics: Adult; Antacids; Biological Availability; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Time Factors | 1986 |
Oral contraception, 1986. Currently available formulations.
Topics: Canada; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Drug Compounding; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; France; Humans; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; United States | 1986 |
Effects of oral contraceptives on carbohydrate metabolism.
Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Levonorgestrel; Norethindrone; Norgestrel | 1986 |
A morphometric study of the effect of oral norethisterone or levonorgestrel on endometrial blood vessels.
Topics: Administration, Oral; Adult; Arteries; Endometrium; Female; Humans; Levonorgestrel; Middle Aged; Myometrium; Norethindrone; Norgestrel; Progesterone; Veins | 1986 |
Progestogen potency in oral contraceptive pills.
Topics: Breast; Cholesterol, HDL; Contraceptives, Oral, Combined; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Phasic approach to oral contraceptives.
Topics: Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Norgestrel; Progesterone | 1987 |
Metabolic effects of combined oral contraceptive preparations.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Contraceptives, Oral, Combined; Female; Follicular Phase; Humans; Hydroxybutyrates; Levonorgestrel; Luteal Phase; Norethindrone; Norgestrel | 1987 |
Progestogen regulation of tissue plasminogen activator in a human melanoma cell line.
Topics: Ethanol; Fibrinolysis; Humans; Levonorgestrel; Medroxyprogesterone; Melanoma; Norethindrone; Norgestrel; Osmolar Concentration; Time Factors; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1988 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
Effect of food-restriction on steady state kinetics and tissue distribution of norethindrone and levonorgestrel in rabbits.
Topics: Animals; Body Weight; Female; Food Deprivation; Levonorgestrel; Metabolic Clearance Rate; Norethindrone; Norgestrel; Organ Size; Rabbits; Tissue Distribution | 1988 |
Vasomotor symptoms and estrogen-progestogen therapy.
Topics: Adult; Climacteric; Contraceptives, Oral, Combined; Estradiol; Estriol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progestins; Vasomotor System | 1985 |
Phase I comparative clinical trial with subdermal implants--bioabsorbable levonorgestrel or norethisterone pellet fused with cholesterol.
Topics: Absorption; Adult; Cervix Mucus; Cholesterol; Contraceptives, Oral, Combined; Drug Combinations; Drug Evaluation; Drug Implants; Female; Fertility; Humans; Levonorgestrel; Menstrual Cycle; Norethindrone; Norgestrel; Uterine Hemorrhage | 1985 |
The effect of progestins on the mitotic activity of uterine fibromyomas.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Leiomyoma; Levonorgestrel; Medroxyprogesterone; Middle Aged; Mitosis; Norethindrone; Norgestrel; Uterine Neoplasms; Uterus | 1985 |
Poly(ortho ester) biodegradable polymer systems.
Topics: Anhydrides; Biodegradation, Environmental; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Kinetics; Levonorgestrel; Methods; Norethindrone; Norgestrel; Polyesters; Solubility | 1985 |
Pharmacokinetics of norethisterone and levonorgestrel in experimental iron deficiency anemia in rabbits.
Topics: Anemia, Hypochromic; Animals; Biological Availability; Female; Kinetics; Levonorgestrel; Norethindrone; Norgestrel; Rabbits | 1985 |
Norethisterone and levonorgestrel esters: a novel synthetic method.
Topics: Acetic Anhydrides; Esters; Fluoroacetates; Levonorgestrel; Methods; Norethindrone; Norgestrel | 1985 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Pharmacokinetic and "potency" of contraceptive steroids.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Female; Humans; Kinetics; Levonorgestrel; Norethindrone; Norgestrel | 1984 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Progestagenic and antigonadotrophic activities of STS 557.
Topics: Administration, Oral; Animals; Chlormadinone Acetate; Contraceptives, Oral, Combined; Female; Gonadotropins; Injections, Subcutaneous; Levonorgestrel; Nandrolone; Norethindrone; Norgestrel; Ovulation; Progesterone Congeners; Rabbits; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Long-acting progestins--promise and prospects.
Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms | 1983 |
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors | 1984 |
Long-acting contraceptive agents: analysis and purification of steroid esters.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Indicators and Reagents; Levonorgestrel; Norethindrone; Norgestrel; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel.
Topics: Animals; Chromatography, Gas; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Hydrolysis; Levonorgestrel; Liver; Norethindrone; Norgestrel; Rabbits; Stereoisomerism; Structure-Activity Relationship | 1983 |
Long-acting contraceptive agents: structure activity relationships in a series of norethisterone and levonorgestrel esters.
Topics: Animals; Biological Assay; Contraceptive Agents; Contraceptives, Oral, Combined; Delayed-Action Preparations; Esters; Estrus; Female; Levonorgestrel; Norethindrone; Norgestrel; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship | 1983 |
Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climacteric women: effect of oestrogen-progestogen therapy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Climacteric; Contraceptives, Oral, Combined; Drug Therapy, Combination; Epoprostenol; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norgestrel; Thromboxane A2; Thromboxanes | 1984 |
Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel | 1984 |
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism | 1981 |
Lipid metabolic studies in oophorectomized women: effects of synthetic progestogens on individual serum phospholipids and serum lecithin fatty acid composition.
Topics: Adult; Castration; Fatty Acids; Female; Humans; Levonorgestrel; Liver Function Tests; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Phosphatidylcholines; Phospholipids; Progesterone Congeners | 1982 |
Binding of the contraceptive steroids norgestrel and norethisterone in human plasma.
Topics: Binding Sites; Binding, Competitive; Blood Proteins; Dihydrotestosterone; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin; Stereoisomerism; Testosterone | 1980 |
[Comparative study of menstrual blood loss with progestagen-releasing intrauterine devices].
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Progesterone | 1981 |
Binding of the gestagens norethisterone and levonorgestrel in blood of various species.
Topics: Animals; Blood Proteins; Dialysis; Dogs; Electrophoresis, Polyacrylamide Gel; Female; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Papio; Protein Binding; Rabbits; Rats; Species Specificity | 1981 |
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies | 1982 |
The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Effects of progestogens on the cardiovascular system.
Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Coronary Disease; Estrogens; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins | 1982 |
The effects of ampicillin on oral contraceptive steroids in women.
Topics: Adult; Ampicillin; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Norethindrone; Norgestrel; Progesterone; Time Factors | 1982 |
Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
Topics: Adult; Brain Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
Effect on blood pressure or changing from high to low dose steroid preparations in women with oral contraceptive induced hypertension.
Topics: Adult; Blood Pressure; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Norethindrone; Norgestrel | 1982 |
Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
Topics: Adult; Blood Glucose; Castration; Contraceptives, Oral, Combined; Female; Glucose Tolerance Test; Humans; Hysterectomy; Insulin; Levonorgestrel; Lipids; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Uterine Cervical Neoplasms | 1982 |
Norethisterone-4 beta,5-oxide and laevonorgestrel-4 beta,5-oxide: formation in rat liver microsomal incubations and interference with microsomal epoxide hydrolase and cytoplasmic glutathione S-transferase.
Topics: Animals; Chromatography, Thin Layer; Cytoplasm; Epoxide Hydrolases; Glutathione Transferase; In Vitro Techniques; Levonorgestrel; Male; Mass Spectrometry; Microsomes, Liver; Mutagenicity Tests; Norethindrone; Norgestrel; Rats | 1981 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Topics: Administration, Oral; Adolescent; Adult; Apolipoprotein A-I; Bilirubin; Body Weight; Cholesterol; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Progestins; Sex Hormone-Binding Globulin; Time Factors; Triglycerides; United States | 1995 |
Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
Topics: Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Implants; Estradiol; Female; Humans; India; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1995 |
Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Topics: Adolescent; Body Weight; Case-Control Studies; Chi-Square Distribution; Child; Condoms; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Implants; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Menstruation; Norethindrone; Norgestrel; Regression Analysis | 1995 |
Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Bottle Feeding; Estradiol; Female; Humans; Lactation; Levonorgestrel; Longitudinal Studies; Norethindrone; Osteocalcin; Progesterone Congeners; Prolactin | 1994 |
The effect of contraceptive steroids on hepatic cholesterol metabolism in female rats (I).
Topics: Acetoacetates; Acetyl-CoA C-Acetyltransferase; Animals; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Hydroxymethylglutaryl-CoA Synthase; Levonorgestrel; Liver; Norethindrone; Norethindrone Acetate; Rats | 1993 |
The effect of contraceptive steroids on plasma lipoprotein metabolism in female rats (II).
Topics: Animals; Apolipoproteins; Cholesterol; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Levonorgestrel; Lipids; Lipoproteins; Norethindrone; Norethindrone Acetate; Phospholipids; Rats; Triglycerides | 1993 |
Contraceptive steroids increase erythrocyte lipid peroxidation in female rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Erythrocyte Membrane; Ethinyl Estradiol; Female; Levonorgestrel; Lipid Peroxidation; Norethindrone; Rats; Rats, Inbred Strains | 1993 |
Enlarged follicles in women using oral contraceptives.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Ovarian Follicle; Ovary; Progestins; Ultrasonography | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
Topics: Adolescent; Adult; Androgen Antagonists; Antibodies; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Immunoenzyme Techniques; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes; Progesterone Congeners; Thrombophlebitis | 1995 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
In vitro molecular assessment of the mechanisms of action of 19-nor progestins used as contragestational agents.
Topics: Animals; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Contraceptives, Oral, Synthetic; Haplorhini; Levonorgestrel; Norethindrone; Progesterone Congeners | 1995 |
Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
Topics: Adult; Aged; Climacteric; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Levonorgestrel; Long-Term Care; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Progestins | 1996 |
Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Topics: Adult; Animals; Antibodies, Monoclonal; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Keratins; Levonorgestrel; Mice; Norethindrone | 1996 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
The effect of oral contraceptive agents on the basal metabolic rate of young women.
Topics: Adult; Anthropometry; Basal Metabolism; Blood Pressure; Body Composition; Calorimetry, Indirect; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Pulse; Stimulation, Chemical; Systole | 1997 |
Endothelin receptor expression in human decidua.
Topics: Abortion, Induced; Biopsy; Collagen; Decidua; Female; Humans; Laminin; Levonorgestrel; Ligands; Menorrhagia; Norethindrone; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Progesterone Congeners; Receptors, Endothelin | 1998 |
Is medical management of menorrhagia obsolete?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Estrogen Replacement Therapy; Female; Humans; Hysteroscopy; Laparoscopy; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid | 1998 |
In vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments.
Topics: Abnormalities, Drug-Induced; Animals; Cells, Cultured; Contraceptives, Oral, Synthetic; Drug Delivery Systems; Female; Levonorgestrel; Norethindrone; Nylons; Pregnancy; Rats; Rats, Wistar | 1998 |
A-ring reduced derivatives of two synthetic progestins induce anxiolytic effects in ovariectomized rats.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Dose-Response Relationship, Drug; Female; Levonorgestrel; Norethindrone; Ovariectomy; Progesterone Congeners; Rats; Rats, Wistar; Reaction Time | 1998 |
Effect of oral contraceptive progestins on serum copper concentration.
Topics: Adolescent; Adult; Androgen Antagonists; Cardiovascular Diseases; Contraceptives, Oral; Copper; Cross-Sectional Studies; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Progestins; Surveys and Questionnaires | 1998 |
Calcium and phosphorus in milk of Brazilian mothers using oral contraceptives.
Topics: Adolescent; Adult; Calcium; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lactation; Levonorgestrel; Milk, Human; Norethindrone; Phosphorus; Regression Analysis | 1998 |
Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988.
Topics: Adult; Body Mass Index; Cross-Sectional Studies; Drug Combinations; Estrogens; Female; Hemodynamics; Hormone Replacement Therapy; Humans; Levonorgestrel; Life Style; Lipids; Middle Aged; Norethindrone; Norway; Postmenopause; Premenopause; Progesterone Congeners | 1998 |
Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects.
Topics: Adult; Androstenes; Cells, Cultured; Collagenases; Contraceptive Agents, Female; Endometrium; Female; Humans; Levonorgestrel; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Pregnenediones; Progesterone; Progesterone Congeners; Stromal Cells; Tissue Inhibitor of Metalloproteinase-1 | 1999 |
Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.
Topics: Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Norethindrone; Patient Satisfaction; Progesterone Congeners; Randomized Controlled Trials as Topic | 1999 |
The pharmacological profile of a novel norpregnance progestin (trimegestone).
Topics: Administration, Oral; Administration, Topical; Animals; Binding, Competitive; Endometrium; Female; Humans; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone; Mice; Norethindrone; Norpregnenes; Progesterone Congeners; Promegestone; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Specific Pathogen-Free Organisms; Uterus | 1999 |
Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
Topics: Aged; Cross-Sectional Studies; Endothelial Growth Factors; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Levonorgestrel; Lymphokines; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Nomenclature of the gonane progestins.
Topics: Estranes; Gonanes; Levonorgestrel; Norethindrone; Terminology as Topic | 1999 |
A pre-coital pill? A preliminary in vitro study.
Topics: Cervix Mucus; Contraceptives, Oral, Synthetic; Female; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Levonorgestrel; Male; Norethindrone; Random Allocation; Sperm Motility | 2000 |
Fine structure of prolactin cell of female albino rat as affected by some antifertility drugs--a comparative electron microscopic study.
Topics: Animals; Contraceptive Agents; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Levonorgestrel; Microscopy, Electron; Norethindrone; Pituitary Gland; Progesterone; Prolactin; Rats; Rats, Wistar; Tamoxifen | 2001 |
Estimation of hormone replacement therapy influence on serum galanin level in postmenopausal women.
Topics: Adult; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Galanin; Humans; Levonorgestrel; Middle Aged; Nandrolone; Norethindrone; Norethindrone Acetate; Postmenopause | 2001 |
Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Topics: Animals; Binding, Competitive; Cell Line; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Estrogens; Gene Expression; Genes, Reporter; Genetic Vectors; Kidney; Levonorgestrel; Mifepristone; Norethindrone; Norpregnenes; Progestins; Promegestone; Promoter Regions, Genetic; Rabbits; Receptors, Progesterone; Response Elements; Transcriptional Activation; Transfection | 2001 |
Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.
Topics: Adult; C-Reactive Protein; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Osmolar Concentration; Postmenopause; Progesterone Congeners; Progestins; Reference Values | 2002 |
Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey.
Topics: Administration, Oral; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Delayed-Action Preparations; Female; Health Surveys; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Lipoproteins; Lynestrenol; Medroxyprogesterone Acetate; Norethindrone; Norway; Progestins; Risk Factors; Triglycerides | 2002 |
Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Topics: Arteriosclerosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Levonorgestrel; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progesterone Congeners; Receptors, Androgen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2002 |
[Comparative study of 4 microdose progestagen - only non-stop oral contraceptives (lynestrenol, D-norgestrel, norethisterone acetate, norgestrienone) on 483 women and 4358 cycles)].
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Evaluation Studies as Topic; Family Planning Services; Levonorgestrel; Lynestrenol; Norethindrone; Progesterone Congeners; Research | 1976 |
Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms | 1982 |
Controlled release of contraceptive steroids from biodegradable poly (ortho esters).
Topics: Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Diagnosis; Family Planning Services; Levonorgestrel; Norethindrone; Reproductive Control Agents | 1983 |
Where next with long-acting steroids?
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Economics; Estradiol; Estrogens; Family Planning Services; Hormones; Injections; Levonorgestrel; Norethindrone; Reproductive Control Agents; Research; Technology | 1984 |
A comparative study of Loestrin versus Nordette in Kelantan, West Malaysia.
Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic | 1984 |
ON 7/7/7 is first choice for 60% of CTU survey respondents.
Topics: Americas; Behavior; Biology; Commerce; Community Health Workers; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Costs and Cost Analysis; Decision Making; Delivery of Health Care; Developed Countries; Developing Countries; Economics; Endocrine System; Family Planning Services; Health; Health Personnel; Health Planning; Hormones; Levonorgestrel; Marketing of Health Services; Norethindrone; North America; Physicians; Physiology; United States | 1987 |
[A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Menstrual Cycle; Menstruation; Norethindrone; Physiology; Reproduction; Reproductive Control Agents; Research | 1987 |
Three triphasic oral contraceptives now available in U.S.
Topics: Americas; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Developing Countries; Endocrine System; Ethinyl Estradiol; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproductive Control Agents; Sexual Behavior; Signs and Symptoms; United States | 1985 |
[Progestins and arterial disease].
Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases | 1985 |
[The triphasic pill].
Topics: Biology; Blood; Blood Coagulation; Blood Pressure; Carbohydrates; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Disease; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Glucose; Hormones; Levonorgestrel; Lipids; Menstruation Disturbances; Metabolism; Norethindrone; Physiology; Reproductive Control Agents; Urogenital System; Uterus | 1985 |
[Influence of progestins on adverse effects of oral contraceptives].
Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents | 1985 |
[Preclinical research and development of norethisterone].
Topics: Animals, Laboratory; Biology; Cervix Mucus; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Economics; Endocrine System; Ethinyl Estradiol; Family Planning Services; Genitalia; Genitalia, Female; Hormones; In Vitro Techniques; Levonorgestrel; Medroxyprogesterone Acetate; Membrane Proteins; Norethindrone; Ovulation; Physiology; Proteins; Reproduction; Reproductive Control Agents; Research; Technology; Urogenital System; Uterus | 1985 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms | 1992 |
[Choosing the right synthetic progestogen].
Topics: Biology; Carbohydrates; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Ethynodiol Diacetate; Family Planning Services; Hormones; Levonorgestrel; Lipids; Metabolism; Norethindrone; Physiology; Progesterone; Progesterone Congeners; Reproductive Control Agents; Therapeutics | 1983 |
Studies on ovarian function in users of the progestagen only contraceptive pill.
Topics: Anovulation; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Diagnosis; Disease; Endocrine System; Endoscopy; England; Ethynodiol Diacetate; Europe; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Levonorgestrel; Norethindrone; Ovarian Cysts; Ovary; Physical Examination; Physiology; Progesterone Congeners; Sexual Behavior; Ultrasonics; United Kingdom; Urogenital System | 1986 |
Oral contraceptives.
Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases | 1987 |
[Comparative study of the effects of three different kinds of oral contraceptives on lipoprotein and apolipoprotein metabolism].
Topics: Asia; Asia, Eastern; Biology; Cardiovascular System; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Desogestrel; Developing Countries; Family Planning Services; Levonorgestrel; Norethindrone; Physiology; Research | 1993 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
The choice of the dose of oestrogen in a combined oral contraceptive.
Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Mestranol; Norethindrone | 1978 |
[Application of the assays for progesterone and estradiol in saliva in family planning research].
Topics: Abortifacient Agents; Abortion, Induced; Asia; Asia, Eastern; Biology; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Developing Countries; Endocrine System; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Levonorgestrel; Norethindrone; Ovary; Physiology; Progesterone; Progestins; Research; Urogenital System | 1987 |
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
Future contraceptive methods.
Topics: Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Family Planning Services; Injections; Intrauterine Devices; Levonorgestrel; Norethindrone; Sterilization, Reproductive | 1994 |
Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Topics: Breast; Breast Neoplasms; Cyproterone; Female; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Levonorgestrel; Medroxyprogesterone; Norethindrone; Progesterone; Progesterone Congeners; Receptors, Estrogen | 2002 |
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
Endogenous estradiol metabolism during treatment with oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Hydroxyestrones; Levonorgestrel; Nandrolone; Norethindrone; Premenopause; Randomized Controlled Trials as Topic | 2004 |
Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins.
Topics: Androgens; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Genes, Reporter; Genetic Vectors; HeLa Cells; Humans; Levonorgestrel; Ligands; Nandrolone; Norethindrone; Norpregnenes; Plasmids; Progestins; Protein Biosynthesis; Receptors, Androgen; Receptors, Progesterone; Transcription, Genetic; Transcriptional Activation; Transfection; Trypsin | 2004 |
Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women.
Topics: Adult; Cardiovascular Diseases; Cause of Death; Coronary Disease; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norway; Regression Analysis | 2004 |
Progestins and estrogens and Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cognition; Estradiol; Estradiol Congeners; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Progesterone Congeners; Rats | 2005 |
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
Topics: Aged; Breast Neoplasms; Cohort Studies; Coronary Disease; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Levonorgestrel; Middle Aged; Multivariate Analysis; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies | 2006 |
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |
A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry.
Topics: Automation; Chromatography, Liquid; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Humans; Levonorgestrel; Norethindrone; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites.
Topics: 5-alpha Reductase Inhibitors; Animals; Calcification, Physiologic; Calcium; Cell Differentiation; Cell Proliferation; Cells, Cultured; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Finasteride; Fulvestrant; Humans; Levonorgestrel; Norethindrone; Osteoblasts; Osteocalcin; Phenols; Progesterone Congeners; Rats; Rats, Wistar | 2007 |
Contraceptive and noncontraceptive benefits of the LNG-IUS in a vertically integrated HMO.
Topics: Adult; Cohort Studies; Family Planning Services; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Norethindrone; Progesterone; Retrospective Studies | 2008 |
Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
Topics: Adolescent; Ambulatory Care Facilities; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Medication Adherence; Norethindrone; Patient Satisfaction; Prospective Studies; Young Adult | 2009 |
Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.
Topics: Caffeine; Endocrine Disruptors; Estradiol; Estriol; Estrogens; Estrone; Hydrogen-Ion Concentration; Levonorgestrel; Medroxyprogesterone; Molecular Structure; Norethindrone; Oxidation-Reduction; Ozone; Pesticides; Pharmaceutical Preparations; Progesterone; Water Pollutants, Chemical; Water Purification; Water Supply | 2009 |
Progest-erone, ogen, in? Which is it?
Topics: Contraceptives, Oral, Combined; Female; Gonadal Steroid Hormones; Humans; Levonorgestrel; Norethindrone; Progesterone; Progestins; Terminology as Topic | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Topics: Adult; Cells, Cultured; Contraceptive Agents, Female; Cytokines; Delayed-Action Preparations; Dendritic Cells; Desogestrel; Female; HIV-1; Humans; Imidazoles; Immune Tolerance; Levonorgestrel; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Norethindrone; Oligodeoxyribonucleotides; Progestins; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
A comparison of progestins within three classes: Differential effects on learning and memory in the aging surgically menopausal rat.
Topics: Aging; Animals; Dose-Response Relationship, Drug; Estrogen Replacement Therapy; Learning; Levonorgestrel; Medroxyprogesterone Acetate; Memory; Models, Animal; Norethindrone; Norethindrone Acetate; Ovariectomy; Progestins; Psychological Tests; Random Allocation; Rats, Inbred F344 | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
Norethindrone acetate versus extended-cycle oral contraceptive (Seasonique
Topics: Adult; Contraceptives, Oral, Synthetic; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Incidence; Intention to Treat Analysis; Intestinal Diseases; Italy; Levonorgestrel; Metrorrhagia; Norethindrone; Norethindrone Acetate; Ovarian Diseases; Pain Measurement; Patient Dropouts; Patient Preference; Pelvic Pain; Prospective Studies; Vaginal Diseases | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Letter to the Editor: "The Use of Norethisterone for the Treatment of Severe Uterine Bleeding in Adolescents: An Audit of Our Experience".
Topics: Adolescent; Female; Humans; Levonorgestrel; Norethindrone; Uterine Hemorrhage | 2020 |
Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.
Topics: Adult; Cells, Cultured; Contraceptive Agents; Endometrium; Epithelial Cells; Female; Fibroblasts; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Progesterone; Wound Healing | 2021 |
Differential off-target glucocorticoid activity of progestins used in endocrine therapy.
Topics: Animals; Chlorocebus aethiops; COS Cells; Glucocorticoids; Interleukin-6; Leukocytes, Mononuclear; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Progestins; Receptors, Glucocorticoid | 2022 |
Development of a Translational Exposure-Bracketing Approach to Streamline the Development of Hormonal Contraceptive Drug Products.
Topics: Contraceptives, Oral; Cytochrome P-450 CYP3A; Female; Humans; Levonorgestrel; Norethindrone; Progestins | 2022 |
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age.
Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism | 2022 |
Development and validation of an expanded panel of progestins using liquid chromatography-tandem triple quadrupole mass spectrometry to monitor protocol compliance in hormonal contraceptive pharmacokinetic/pharmacodynamic studies.
Topics: Chromatography, Liquid; Clinical Trials as Topic; Contraceptive Agents; Guideline Adherence; Humans; Levonorgestrel; Mass Spectrometry; Norethindrone; Progestins; Reproducibility of Results | 2023 |